| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Award | $0 | +64,897 | +29% | $0.000000 | 284,956 | 25 Feb 2025 | Direct | F1 |
| holding | ABT | Common shares without par value | 197,403 | 25 Feb 2025 | Ford Family Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Option (right to buy) | Award | $0 | +241,706 | $0.000000 | 241,706 | 25 Feb 2025 | Common Shares | 241,706 | $135.42 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. |
| F2 | Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust. |
| F3 | Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 80,568 on February 25, 2026, 80,569 on February 25, 2027, and 80,569 on February 25, 2028. |